Evidence map›Paper›PMID 34224169›Full record

ArticleEuropean journal of cancer care2021

Family history of cancer in first degree relatives and risk of cancer of unknown primary.

Alexander L R Grewcock, Karlijn E P E Hermans, Matty P Weijenberg, Piet A van den Brandt, Caroline Loef, Rob L H Jansen, Leo J Schouten

Open access · greenAbstract read
In one paragraph

Article in European journal of cancer care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alexander L R GrewcockDepartment of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.
Karlijn E P E HermansDepartment of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.ORCID https://orcid.org/0000-0002-7629-0820
Matty P WeijenbergDepartment of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.
Piet A van den BrandtDepartment of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.ORCID https://orcid.org/0000-0001-8781-8099
Caroline LoefDepartment of Research, Netherlands Comprehensive Cancer Organisation, Groningen, Netherlands.ORCID https://orcid.org/0000-0002-6911-5725
Rob L H JansenDepartment of Internal Medicine, Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, Netherlands.
Leo J SchoutenDepartment of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.ORCID https://orcid.org/0000-0003-3361-7560
Maastricht University · NLMaastricht University Medical Centre · NLNetherlands Comprehensive Cancer Organisation · NL

Funding

World Cancer Research Fund International 2017/1628
6 · The paper itself

Abstract

objectiveCancer of Unknown Primary (CUP) refers to the presence of metastatic lesions, with no identifiable primary site during the patient's lifetime. Poor survival and lack of available treatment highlight the need to identify potential CUP risk factors. We investigated whether a family history of cancer is associated with increased CUP risk.

methodsWe performed a case cohort analysis using data from the Netherlands Cohort Study, which included a total of 963 CUP cases and 4,288 subcohort members. A Cox Proportional Hazards Regression was used to compare CUP risk in participants who reported to have a family member with cancer to those who did not, whilst adjusting for confounders.

resultsIn general, we observed no increased CUP risk in those who reported a family history of cancer. CUP risk appeared slightly increased in those who reported cancer in a sibling (HR: 1.16, 95% CI: 0.97-1.38), especially in those with a sister with cancer compared with those without (HR: 1.23, 95% CI: 0.99-1.53), although these findings are not statistically significant.

conclusionHaving a family history of cancer is not an independent risk factor of CUP.

Indexed as

Neoplasms, Unknown PrimaryCohort StudiesFamilyHumansNetherlandsRisk FactorsCancer of Unknown Primary (CUP)family history of cancerprospective cohort study

Identifiers

PMID34224169
PMCPMC9285374
OpenAlexW3182009176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.